Analysis finds savings with transradial access

03/31/2013 | CardiovascularBusiness.com

Percutaneous coronary intervention using the transradial approach reduces hospital costs by an average of $553 compared with the transfemoral route, largely due to shorter post-procedure hospital stays, according to an analysis published in the American Heart Journal. Low-, medium- and high-risk patients in the transradial group all experienced a lower rate of in-hospital bleeding complications than those who received transfemoral treatment, according to the study.

View Full Article in:

CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN